{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:04:57Z","timestamp":1792231497231,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93737-4","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:56:23Z","timestamp":1742590583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson\u2019s disease models via PMK-1\/p38 MAPK and SKN-1\/Nrf2 signaling"],"prefix":"10.1038","volume":"15","author":[{"given":"Marcos","family":"Francisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"93737_CR1","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso, J. A. et al. Past, present, and future of Parkinson\u2019s disease: a special assay on the 200th anniversary of the shaking palsy. Mov. Disord. 32, 1264\u20131310 (2017).","journal-title":"Mov. Disord."},{"key":"93737_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-1814474","volume":"8","author":"E Dorsey","year":"2018","unstructured":"Dorsey, E., Sherer, T., Okun, M. & Bloem, B. The emerging evidence of the Parkinson pandemic. J. Park. Dis. 8, S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-1814474 (2018).","journal-title":"J. Park. Dis."},{"key":"93737_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Gigu\u00e9re","year":"2018","unstructured":"Gigu\u00e9re, N., Nanni, S. B. & Trudeau, L. E. On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front. Neurol. 9, 455. https:\/\/doi.org\/10.3389\/fneur.2018.00455 (2018).","journal-title":"Front. Neurol."},{"key":"93737_CR4","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045 (1997).","journal-title":"Science"},{"key":"93737_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"J Bendor","year":"2013","unstructured":"Bendor, J., Logan, T. & Edwards, R. The function of \u03b1-Synuclein. Neuron. 79, 6. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004 (2013).","journal-title":"Neuron."},{"key":"93737_CR6","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","volume":"185","author":"E Hallacli","year":"2022","unstructured":"Hallacli, E. et al. The Parkinson\u2019s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell 185, 2035\u20132056. https:\/\/doi.org\/10.1016\/j.cell.2022.05.008 (2022).","journal-title":"Cell"},{"key":"93737_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-802395-2.00024-9","volume":"145","author":"I Alafuzoff","year":"2017","unstructured":"Alafuzoff, I. & Hartikainen, P. Alpha-synucleinopathies. Hanbd. Clin. Neurol. 145, 339\u2013353 (2017).","journal-title":"Hanbd. Clin. Neurol."},{"key":"93737_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256\u2013259. https:\/\/doi.org\/10.1126\/science.1077209 (2003).","journal-title":"Science"},{"key":"93737_CR9","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/nejm200005253422103","volume":"342","author":"CB L\u00fccking","year":"2000","unstructured":"L\u00fccking, C. B. et al. Association between early-onset Parkinson\u2019s disease and mutations in the Parkin gene. N. Engl. J. Med. 342, 1560\u20131567. https:\/\/doi.org\/10.1056\/nejm200005253422103 (2000).","journal-title":"N. Engl. J. Med."},{"key":"93737_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente, E. M. et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304, 1158\u20131160. https:\/\/doi.org\/10.1126\/science.1096284 (2004).","journal-title":"Science"},{"key":"93737_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphich pathology. Neuron 44, 601\u2013607 (2004).","journal-title":"Neuron"},{"key":"93737_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein, C. & Westerberger, A. Genetics of Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 2, a008888 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"93737_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/JPD-202521","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Non-genetic risk factors for Parkinson\u2019s disease: an overview of 46 systematic reviews. J. Park. Dis. 11, 919\u2013935. https:\/\/doi.org\/10.3233\/JPD-202521 (2021).","journal-title":"J. Park. Dis."},{"key":"93737_CR14","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","volume":"260","author":"MG Cersosimo","year":"2013","unstructured":"Cersosimo, M. G. et al. Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms. J. Neurol. 260, 1332\u20131338. https:\/\/doi.org\/10.1007\/s00415-012-6801-2 (2013).","journal-title":"J. Neurol."},{"key":"93737_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-018-0539-9","volume":"20","author":"RF Pfeiffer","year":"2018","unstructured":"Pfeiffer, R. F. Gastrointestinal dysfunction in Parkinson\u2019s disease. Curr. Treat. Opt. Neurol. 20, 54. https:\/\/doi.org\/10.1007\/s11940-018-0539-9 (2018).","journal-title":"Curr. Treat. Opt. Neurol."},{"key":"93737_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","volume":"1693","author":"RA Liddle","year":"2018","unstructured":"Liddle, R. A. Parkinson\u2019s disease from the gut. Brain Res. 1693, 201\u2013206. https:\/\/doi.org\/10.1016\/j.brainres.2018.01.010 (2018).","journal-title":"Brain Res."},{"key":"93737_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.25298","volume":"28","author":"A Gold","year":"2013","unstructured":"Gold, A., Turkalp, Z. T. & Munoz, D. G. Enteric alpha-synuclein expression is increased in Parkinson\u2019s disease but not Alzheimer\u2019s disease. J. Mov. Disord. Soc. 28, 237\u2013240. https:\/\/doi.org\/10.1002\/mds.25298 (2013).","journal-title":"J. Mov. Disord. Soc."},{"key":"93737_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnagi.2020.00012","volume":"12","author":"R Franco","year":"2020","unstructured":"Franco, R., Rivas-Santisteban, R., Reyes-Resina, I., Navarro, G. & Mart\u00ednez-Pinilla, E. Microbiota and other preventive strategies and non-genetic risk factors in Parkinson\u2019s disease. Front. Aging Neurosci. 12, 12. https:\/\/doi.org\/10.3389\/fnagi.2020.00012 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"93737_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/archneur.64.9.1242","volume":"64","author":"G Levy","year":"2007","unstructured":"Levy, G. The relationship of Parkinson disease with aging. Arch. Neurol. 64, 1242\u20131246 (2007).","journal-title":"Arch. Neurol."},{"key":"93737_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/acel.12312","volume":"14","author":"M Rodriguez","year":"2015","unstructured":"Rodriguez, M., Rodriguez-Sabate, C., Morales, I., Sanchez, A. & Sabate, M. Parkinson\u2019s disease as a result of aging. Aging Cell 14, 293\u2013308 (2015).","journal-title":"Aging Cell"},{"key":"93737_CR21","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/npjparkd.2015.22","volume":"1","author":"J Cooper","year":"2015","unstructured":"Cooper, J. et al. Delaying aging is neuroprotective in Parkinson\u2019s disease: a genetic analysis in C. elegans models. Nat. Parkin. Dis. 1, 15022. https:\/\/doi.org\/10.1038\/npjparkd.2015.22 (2015).","journal-title":"Nat. Parkin. Dis."},{"key":"93737_CR22","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1073\/pnas.0705467105","volume":"105","author":"Y Suh","year":"2008","unstructured":"Suh, Y. et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. USA 105, 3438\u20133442 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"93737_CR23","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3389\/fmicb.2017.01666","volume":"8","author":"ON Ilinskaya","year":"2017","unstructured":"Ilinskaya, O. N., Ulyanova, V. V., Yarullina, D. R. & Gataullin, I. G. Secretome of intestinal Bacilli: a natural guard against pathologies. Front. Microbiol. 8, 1666. https:\/\/doi.org\/10.3389\/fmicb.2017.01666 (2017).","journal-title":"Front. Microbiol."},{"key":"93737_CR24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","volume":"562","author":"P Piewngam","year":"2018","unstructured":"Piewngam, P. et al. Pathogen elimination by probiotic Bacillus via signalling interference. Nature 562, 532\u2013537. https:\/\/doi.org\/10.1038\/s41586-018-0616-y (2018).","journal-title":"Nature"},{"key":"93737_CR25","doi-asserted-by":"publisher","first-page":"1253480","DOI":"10.3389\/fmicb.2023.1253480","volume":"14","author":"C Le\u00f1ini","year":"2023","unstructured":"Le\u00f1ini, C. et al. Probiotic properties of Bacillus subtilis DG101 isolated from the traditional Japanese fermented food natto. Front. Microbiol. 14, 1253480. https:\/\/doi.org\/10.3389\/fmicb.2023.1253480 (2023).","journal-title":"Front. Microbiol."},{"key":"93737_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14332","volume":"8","author":"V Donato","year":"2017","unstructured":"Donato, V. et al. Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway. Nat. Commun. 8, 1\u201315. https:\/\/doi.org\/10.1038\/ncomms14332 (2017).","journal-title":"Nat. Commun."},{"key":"93737_CR27","unstructured":"Grau, R. & Francisco, M. Probiotic Bacillus subtilis DG101 prevents alpha-synuclein aggregation and extends the healthy lifespan in Parkinson disease model Caenorhabditis elegans. Advances in Alzheimer & Parkinson Therapies AN AAT\/AD Focus Meeting; Torino, Italy. https:\/\/www.alzforum.org\/news\/conference-coverage\/do-immune-responses-promote-or-prevent-parkinsons-disease (2018)."},{"key":"93737_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.celrep.2019.12.078","volume":"30","author":"ME Goya","year":"2020","unstructured":"Goya, M. E. et al. Probiotic Bacillus subtilis protects against \u03b1-synuclein aggregation in C.\u00a0elegans. Cell Rep. 30, 367\u20133807. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.078 (2020).","journal-title":"Cell Rep."},{"issue":"1","key":"93737_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.36502\/2022\/ASJBCCR.6263","volume":"5","author":"AF Rodriguez","year":"2022","unstructured":"Rodriguez, A. F., Cardinali, N. & Grau, R. Efficient weight loss and type II diabetes control in overweight and obese patients consuming the probiotic Bacillus subtilis DG101: a randomized double-blind placebo-controlled study. Asploro J. Biomed. Clin. Case Rep. 5(1), 51\u201358. https:\/\/doi.org\/10.36502\/2022\/ASJBCCR.6263 (2022).","journal-title":"Asploro J. Biomed. Clin. Case Rep."},{"key":"93737_CR30","doi-asserted-by":"publisher","DOI":"10.58489\/2836-5070\/013","author":"N Cardinali","year":"2024","unstructured":"Cardinali, N., Rodriguez, A. F., Le\u00f1ini, C. & Grau, R. Efficacy of the probiotic Bacillus subtilis DG101 to prevent overweight in healthy individuals: a double blind, placebo-controlled study. J. Obes. Fit. Manag. https:\/\/doi.org\/10.58489\/2836-5070\/013 (2024).","journal-title":"J. Obes. Fit. Manag."},{"key":"93737_CR31","doi-asserted-by":"publisher","DOI":"10.47991\/2834-5231\/ACMCRR-118","author":"AF Rodriguez","year":"2024","unstructured":"Rodriguez, A. F., Le\u00f1ini, C., Cardinali, N. & Grau, R. A double blind, placebo-controlled study to evaluate the efficacy of probiotic Bacillus subtilis DG101 in maintaining blood sugar homeostasis in healthy adults. Ann. Clin. Med. Case Rep. Rev. https:\/\/doi.org\/10.47991\/2834-5231\/ACMCRR-118 (2024).","journal-title":"Ann. Clin. Med. Case Rep. Rev."},{"key":"93737_CR32","doi-asserted-by":"publisher","DOI":"10.47991\/2835-9496\/AJCMR-129","author":"N Cardinali","year":"2024","unstructured":"Cardinali, N., Rodriguez, A. F., Le\u00f1ini, C., Perez, O. & Grau, R. Efficacy of the probiotic Bacillus subtilis DG101 against intestinal disconfort and constipation in healthy adults: a double-blind, placebo-controlled study. Am. J. Clin. Med. Res. https:\/\/doi.org\/10.47991\/2835-9496\/AJCMR-129 (2024).","journal-title":"Am. J. Clin. Med. Res."},{"key":"93737_CR33","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1038\/s41598-017-07222-8","volume":"7","author":"O Smolentseva","year":"2017","unstructured":"Smolentseva, O. et al. Mechanism of biofilm-mediated stress resistance and lifespan extension in C. elegans. Sci. Rep. 7, 7137. https:\/\/doi.org\/10.1038\/s41598-017-07222-8 (2017).","journal-title":"Sci. Rep."},{"key":"93737_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.chom.2007.05.004","volume":"1","author":"M Fujiya","year":"2007","unstructured":"Fujiya, M. et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 1, 299\u2013308 (2007).","journal-title":"Cell Host Microbe"},{"key":"93737_CR35","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5157-04.2005","volume":"25","author":"S Cao","year":"2005","unstructured":"Cao, S., Gelwix, C. C., Caldwell, K. A. & Caldwell, G. A. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25, 3801\u20133812. https:\/\/doi.org\/10.1523\/JNEUROSCI.5157-04.2005 (2005).","journal-title":"J. Neurosci."},{"key":"93737_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0020183","volume":"2","author":"E Troemel","year":"2006","unstructured":"Troemel, E., Chu, S., Reinke, V., Ausubel, F. & Kim, D. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2, e183. https:\/\/doi.org\/10.1371\/journal.pgen.0020183 (2006).","journal-title":"PLoS Genet."},{"key":"93737_CR37","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1534\/genetics.116.198788","volume":"206","author":"Q Hu","year":"2017","unstructured":"Hu, Q., D\u2019Amora, D., MacNeil, L., Walhout, A. & Kubiseski, T. The oxidative stress response in Caenorhabditis elegans requires the GATA transcription factor ELT-3 and SKN-1\/Nrf2. Genetics. 206, 1909\u20131922. https:\/\/doi.org\/10.1534\/genetics.116.198788 (2017).","journal-title":"Genetics."},{"key":"93737_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrn3039","volume":"12","author":"TJ Collier","year":"2011","unstructured":"Collier, T. J., Kanaam, N. M. & Kordower, J. H. Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat. Rev. Neurosci. 12, 359\u2013366 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"93737_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392\u2013395 (2009).","journal-title":"Nature"},{"key":"93737_CR40","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0405831102","volume":"101","author":"N Maswood","year":"2004","unstructured":"Maswood, N. et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 101, 18171\u201318176 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"93737_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008758","volume":"5","author":"B Onken","year":"2010","unstructured":"Onken, B. & Driscoll, M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One 5, e8758 (2010).","journal-title":"PLoS One"},{"key":"93737_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","volume":"277","author":"SP Patil","year":"2014","unstructured":"Patil, S. P., Jain, P. D., Ghumatkar, P. J., Tambe, R. & Sathaye, S. Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice. Neuroscience 277, 747\u2013754 (2014).","journal-title":"Neuroscience"},{"key":"93737_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.1078223","volume":"299","author":"M Bluher","year":"2003","unstructured":"Bluher, M., Kahn, B. B. & Kahn, C. R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572\u2013574 (2003).","journal-title":"Science"},{"key":"93737_CR44","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ncpneuro0924","volume":"4","author":"C Henchcliffe","year":"2008","unstructured":"Henchcliffe, C. & Beal, M. F. Mitochondrial biology and oxidative stress in Parkinson\u2019s disease pathogenesis. Nat. Clin. Pract. Beurol. 4, 600\u2013609 (2008).","journal-title":"Nat. Clin. Pract. Beurol."},{"key":"93737_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1196\/annals.1427.023","volume":"1147","author":"C Zhou","year":"2008","unstructured":"Zhou, C., Huang, Y. & Przedborski, S. Oxidative stress in Parkinson\u2019s disease, a mechanism of pathologic and therapeutic significance. Ann. N. Y. Acad. Sci. 1147, 93\u2013104. https:\/\/doi.org\/10.1196\/annals.1427.023 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"93737_CR46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/wnl:1346-50","volume":"50","author":"JM Gorrel","year":"1998","unstructured":"Gorrel, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L. & Richardson, R. J. The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living. Neurology 50, 1346\u20131350. https:\/\/doi.org\/10.1212\/wnl:1346-50 (1998).","journal-title":"Neurology"},{"key":"93737_CR47","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/toxsci\/kfq285","volume":"118","author":"N Vanduyn","year":"2010","unstructured":"Vanduyn, N., Settivari, R., Wong, G. & Nass, R. SKN-1\/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity. Toxicol. Sci. 118, 613\u2013624. https:\/\/doi.org\/10.1093\/toxsci\/kfq285 (2010).","journal-title":"Toxicol. Sci."},{"key":"93737_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuro.2013.05.014","volume":"38","author":"R Settivari","year":"2013","unstructured":"Settivari, R., VanDuyn, N., LeVora, J. & Nass, R. The Nrf2\/SKN-1-dependent glutathione S-transferase \u03c0 homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism. Neuro Toxicol. 38, 51\u201360. https:\/\/doi.org\/10.1016\/j.neuro.2013.05.014 (2013).","journal-title":"Neuro Toxicol."},{"key":"93737_CR49","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00438-017-1351-z","volume":"292","author":"A Keshet","year":"2017","unstructured":"Keshet, A. et al. PMK-1 p38 MAPK promotes cadmium stress resistance, the expression of SKN-1\/Nrf and DAF-16 target genes, and protein biosynthesis in Caenorhabditis elegans. Mol. Genet. Genom. 292, 1341\u20131361. https:\/\/doi.org\/10.1007\/s00438-017-1351-z (2017).","journal-title":"Mol. Genet. Genom."},{"key":"93737_CR50","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1073\/pnas.0607260103","volume":"103","author":"C Clements","year":"2006","unstructured":"Clements, C., McNally, R., Conti, B., Mak, T. & Ting, J. DJ-1, a cancer- and Parkinson\u2019s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. 103, 15091\u201315096. https:\/\/doi.org\/10.1073\/pnas.0607260103 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"93737_CR51","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/antiox1011649","volume":"10","author":"JA Parga","year":"2021","unstructured":"Parga, J. A., Rodriguez-Perez, A. I., Garcia-Garrote, M., Rodriguez-Pallares, J. & Labandeira-Garc\u00eda, J. Nrf2 activation and downstream effects: focus on Parkinson\u2019s disease and brain angiotensin. Antioxidans 10, 1649. https:\/\/doi.org\/10.3390\/antiox1011649 (2021).","journal-title":"Antioxidans"},{"key":"93737_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/fphar.2022.919233","volume":"13","author":"X-X Yang","year":"2022","unstructured":"Yang, X.-X., Yang, R. & Zhang, F. Role of Nrf2 in Parkinson\u2019s disease: toward new perspectives. Front. Pharmacol. 13, 919233. https:\/\/doi.org\/10.3390\/fphar.2022.919233 (2022).","journal-title":"Front. Pharmacol."},{"key":"93737_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/antiox12030673","volume":"12","author":"J Segura-Aguilar","year":"2023","unstructured":"Segura-Aguilar, J. & Mannervik, B. A preclinical model for Parkinson\u2019s disease based on transcriptional gene activation via KEAP1\/NRF2 to develop new antioxidant therapies. Antioxidants 12, 673. https:\/\/doi.org\/10.3390\/antiox12030673 (2023).","journal-title":"Antioxidants"},{"key":"93737_CR54","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"Z Wallen","year":"2022","unstructured":"Wallen, Z. et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 13, 6958. https:\/\/doi.org\/10.1038\/s41467-022-34667-x (2022).","journal-title":"Nat. Commun."},{"key":"93737_CR55","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1080\/10408398.2018.1484340","volume":"59","author":"A Larroya-Garc\u00eda","year":"2019","unstructured":"Larroya-Garc\u00eda, A., Navas-Carrillo, D. & Orenes-Pi\u00f1ero, E. Impact of gut microbiota on neurological diseases: Diet composition and novel treatments. Crit. Rev. Food Sci. Nutr. 59, 3102\u20133116. https:\/\/doi.org\/10.1080\/10408398.2018.1484340 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"93737_CR56","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/ijms20030719","volume":"20","author":"M Van Bulck","year":"2019","unstructured":"Van Bulck, M., Sierra-Magro, A., Alarcon-Gil, J., Perez-Castillo, A. & Morales-Garcia, J. A. Novel approaches for the treatment of Alzheimer\u2019s and Parkinson\u2019s disease. Int. J. Mol. Sci. 20, 719. https:\/\/doi.org\/10.3390\/ijms20030719 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"93737_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.15698\/mic2017.04.569","volume":"16","author":"FR Ayala","year":"2017","unstructured":"Ayala, F. R. et al. Microbial flora, probiotics, Bacillus subtilis and the search for a long and healthy human longevity. Microb. Cell. 16(4), 133\u2013136. https:\/\/doi.org\/10.15698\/mic2017.04.569 (2017).","journal-title":"Microb. Cell."},{"key":"93737_CR58","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.tins.2013.03.003","volume":"36","author":"J Roeper","year":"2013","unstructured":"Roeper, J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci. 36, 336\u2013342. https:\/\/doi.org\/10.1016\/j.tins.2013.03.003 (2013).","journal-title":"Trends Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93737-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:56:28Z","timestamp":1742590588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93737-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93737"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93737-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9864"}}